BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6482001)

  • 61. [Effect of shenqiwan on immunological function in the nephrotic syndrome of chronic glomerulonephritis patients].
    Wang J; Zhang DS
    Zhong Xi Yi Jie He Za Zhi; 1987 Dec; 7(12):731-3, 709. PubMed ID: 3502398
    [No Abstract]   [Full Text] [Related]  

  • 62. [Studies of complement, nephritic factor, and circulating immune complexes in chronic mesangiocapillary glomerulonephritis types I and II (author's transl)].
    Mirapeix E; Yagüe J; Vives J; Revert L
    Med Clin (Barc); 1981 Jun; 77(1):21-6. PubMed ID: 7253758
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunologic studies in patients with glomerulonephritis.
    Belovezhdov N; Altankova I
    Clin Nephrol; 1982 Mar; 17(3):141-8. PubMed ID: 7067176
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Production of nephritic factor of the alternative complement pathway by Epstein Barr virus-transformed B cell lines derived from a patient with membranoproliferative glomerulonephritis.
    Hiramatsu M; Balow JE; Tsokos GC
    J Immunol; 1986 Jun; 136(12):4451-5. PubMed ID: 3011894
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Complement consumption and progression to post-streptococcal nephrotic syndrome. A report of two cases.
    Diedericks R; Coovadia HM
    S Afr Med J; 1978 Jul; 54(5):208-10. PubMed ID: 705557
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Circulating immune complexes and glomerulonephritis in a patient with congenital absence of the third component of complement.
    Berger M; Balow JE; Wilson CB; Frank MM
    N Engl J Med; 1983 Apr; 308(17):1009-12. PubMed ID: 6835307
    [No Abstract]   [Full Text] [Related]  

  • 67. [Association of monoclonal gammopathy with chronic glomerulonephritis and autoimmune hyperlipemia. Course of disease during therapy].
    Sobel AT; Antonucci M; Intrator L; Bernard D; Beaumont JL; Lagrue G
    Nouv Presse Med; 1976 Oct; 5(36):2375-8. PubMed ID: 1068625
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cyclosporine treatment in patients with primary glomerular diseases.
    Tejani A
    Int J Pediatr Nephrol; 1987; 8(1):1-3. PubMed ID: 3583551
    [No Abstract]   [Full Text] [Related]  

  • 69. Measles and acute glomerulonephritis.
    Lin CY; Hsu HC
    Pediatrics; 1983 Mar; 71(3):398-401. PubMed ID: 6219335
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Immunosuppressors and immunostimulants in the treatment of chronic glomerulonephritis patients with the nephrotic syndrome].
    Nazar PS
    Vrach Delo; 1987 Mar; (3):86-9. PubMed ID: 3590711
    [No Abstract]   [Full Text] [Related]  

  • 71. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F; Kijlstra A
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An affinity for complement C3 as a possible reason for the potency of naturally occurring antibodies in mediating tissue homeostasis.
    Lutz HU; Fasler S; Stammler P
    Beitr Infusionsther; 1989; 24():193-9. PubMed ID: 2481539
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of the nephrotic syndrome on the concentration of serum complement components.
    Strife CF; Jackson EC; Forristal J; West CD
    Am J Kidney Dis; 1986 Jul; 8(1):37-42. PubMed ID: 3728461
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Nephrotic syndrome in a 52-year-old woman with monoclonal gammopathy.
    Levitan D; Boylen TC; Kamil ES; Koss MN
    Am J Nephrol; 1981; 1(3-4):199-205. PubMed ID: 6817641
    [No Abstract]   [Full Text] [Related]  

  • 75. Evidence for cell-mediated immunity to renal antigens in minimal-change nephrotic syndrome.
    Eyres K; Mallick NP; Taylor G
    Lancet; 1976 May; 1(7970):1158-9. PubMed ID: 58202
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Prognostic aspects of immune disorders in glomerulonephritis in children].
    Shilenok IG; Borodinova IKh; Kochetkova SI; Dar'ina TM
    Pediatriia; 1988; (5):14-8. PubMed ID: 2971923
    [No Abstract]   [Full Text] [Related]  

  • 77. [Cytomegalovirus infection and glomerulonephritis].
    Semidotskaia ZhD; Artemova SN
    Lik Sprava; 1999 Jun; (4):77-83. PubMed ID: 10476650
    [TBL] [Abstract][Full Text] [Related]  

  • 78. C1q nephropathy presenting as nephritic-nephrotic syndrome.
    Bhowmik DM; Jain S; Dinda AK; Sharma A; Mahajan S; Agarwal SK
    Saudi J Kidney Dis Transpl; 2011 May; 22(3):561-3. PubMed ID: 21566322
    [No Abstract]   [Full Text] [Related]  

  • 79. [Relationship between proteinase inhibitory activity of plasma alpha 2-macroglobulin and depressed cell immunity in idiopathic nephrotic syndrome].
    Asami T; Nisihara T; Hayashi M; Sakai K
    Nihon Jinzo Gakkai Shi; 1988 Aug; 30(8):935-41. PubMed ID: 2468803
    [No Abstract]   [Full Text] [Related]  

  • 80. [The regulatory link in the immune system in glomerulonephritis in children].
    Chebotareva VD; Bagdasarova IV; Maĭdannik VG
    Pediatriia; 1984 Jun; (6):26-9. PubMed ID: 6236419
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.